SCHEMBL21137692

SCHEMBL21137692

c1ccc(-n2c3ccccc3c3c4c5ccccc5n(-c5ccc6oc7ccccc7c6c5)c4c4c5ccccc5n(-c5ccccc5)c4c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 3/20 0.37
POLB P06746 2/20 0.37
TSHR P16473 1/20 0.37
BRCA1 P38398 1/20 0.37
HSD17B10 Q99714 1/20 0.37
AHR P35869 2/20 0.36
PPARG P37231 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NR2E3 Q9Y5X4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21109302 0.97 KDM4E (0.43) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL19997974 0.93 KDM4E (0.40) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17245532 0.93 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17123108 0.93 KDM4E (0.42) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17406091 0.92 ALDH1A1 (0.38) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17405318 0.92 ALDH1A1 (0.38) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17123079 0.92 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17245530 0.92 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21108876 0.92 KDM4E (0.41) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL21108871 0.92 KDM4E (0.41) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190198776-A1 COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190198776-A1 COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OCIAD2, OXER1 KDM4E 4755/4885ATM 3934/4885L3MBTL1 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.